Flow CytometryClinical Trials as TopicRegional Blood FlowImage CytometryBlood Flow VelocityLaser Scanning CytometryImmunophenotypingApoptosisTime FactorsAntigens, CDCells, CulturedCell SeparationCell Line, TumorFluorescent DyesPloidiesAntibodies, MonoclonalCell CycleDouble-Blind MethodPulsatile FlowCell ProliferationStaining and LabelingClinical Trials, Phase III as TopicTreatment OutcomeGene FlowResearch DesignDose-Response Relationship, DrugMicrospheresCell SurvivalPropidiumT-LymphocytesMonocytesClinical Trials, Phase II as TopicFluorescein-5-isothiocyanateAntineoplastic AgentsCD4-Positive T-LymphocytesClinical Trials, Phase I as TopicAntigens, CD45Controlled Clinical Trials as TopicLeukocytes, MononuclearReproducibility of ResultsFluoresceinsSensitivity and SpecificityCell LineProspective StudiesBiological MarkersMicroscopy, FluorescenceLymphocyte CountTumor Cells, CulturedCell DivisionCytokinesReverse Transcriptase Polymerase Chain ReactionFluorescenceRNA, MessengerFollow-Up StudiesLymphocytesLeukocytesCell-Derived MicroparticlesAnnexin A5Lymphocyte SubsetsImmunohistochemistryCell CountDNA, NeoplasmMicroscopy, ConfocalBlotting, WesternEnzyme-Linked Immunosorbent AssayB-LymphocytesLymphocyte ActivationCD8-Positive T-LymphocytesPlatelet ActivationT-Lymphocyte SubsetsRheologyNeutrophilsBone Marrow CellsInterferon-gammaMice, Inbred BALB CCell DifferentiationAntigens, CD3PlacebosCerebrovascular CirculationBlood PlateletsPhenotypeMembrane GlycoproteinsMice, Inbred C57BLFluorescent Antibody TechniqueSingle-Blind MethodCoronary CirculationGreen Fluorescent ProteinsBlood CellsAneuploidyAntigens, CD34Antigens, SurfaceGene ExpressionPrognosisCell AdhesionUp-RegulationNeoplasmsDendritic CellsEndothelial CellsClinical ProtocolsPatient Selection